Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia.
暂无分享,去创建一个
[1] I. van Ark,et al. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. , 1993, The American review of respiratory disease.
[2] D. Venzon,et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. , 1993, The Journal of clinical investigation.
[3] S. Durham,et al. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. , 1993, American journal of respiratory cell and molecular biology.
[4] D. Laskin,et al. Isolation and partial characterization of subpopulations of alveolar macrophages, granulocytes, and highly enriched interstitial macrophages from rat lung. , 1993, American journal of respiratory cell and molecular biology.
[5] K. Takatsu,et al. CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. , 1992, The American review of respiratory disease.
[6] S. Durham,et al. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. , 1992, The American review of respiratory disease.
[7] J. Virchow,et al. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. , 1992, The American review of respiratory disease.
[8] P. W. Johnston,et al. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. , 1992, The American review of respiratory disease.
[9] S. Durham,et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.
[10] K. Weinberg,et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.
[11] K. Blaser,et al. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. , 1991, The Journal of allergy and clinical immunology.
[12] T. Suda,et al. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. , 1991, Blood.
[13] C. Rochester,et al. Is asthma T-cell mediated? , 1991, The American review of respiratory disease.
[14] H. Jansen,et al. Functional subsets of allergen-reactive human CD4+ T cells. , 1991, Immunology today.
[15] G. Peltz. A Role for CD4+ T‐Cell Subsets Producing a Selective Pattern of Lymphokines in the Pathogenesis of Human Chronic Inflammatory and Allergic Diseases , 1991, Immunological reviews.
[16] H. van Loveren,et al. T-cell-mediated induction of airway hyperreactivity in mice. , 1991, The American review of respiratory disease.
[17] J. Curtis,et al. Requirement of CD4-positive T cells for cellular recruitment to the lungs of mice in response to a particulate intratracheal antigen. , 1991, The Journal of clinical investigation.
[18] F. Finkelman,et al. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. , 1991, Journal of immunology.
[19] Roberta,et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. , 1991, The Journal of clinical investigation.
[20] L. Allegra,et al. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. , 1991, The Journal of allergy and clinical immunology.
[21] M. Schuyler,et al. Dynamic T-cell changes in peripheral blood and bronchoalveolar lavage after antigen bronchoprovocation in asthmatics. , 1991, The American review of respiratory disease.
[22] S. Durham,et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. , 1990, The American review of respiratory disease.
[23] J. Bousquet,et al. Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.
[24] C. Corrigan,et al. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. , 1990, The American review of respiratory disease.
[25] J. Snapper. Inflammation and airway function: the asthma syndrome. , 1990, The American review of respiratory disease.
[26] G. Gleich. The eosinophil and bronchial asthma: current understanding. , 1990, The Journal of allergy and clinical immunology.
[27] A. Kay,et al. T lymphocytes and eosinophils in allergen-induced late-phase asthmatic reactions in the guinea pig. , 1990, The American review of respiratory disease.
[28] Ji Ming Wang,et al. Recombinant human interleukin 5 is a selective eosinophil chemoattractant , 1989, European journal of immunology.
[29] J. Curtis,et al. Characterization of bronchoalveolar lymphocytes during a specific antibody-forming cell response in the lungs of mice. , 1989, The American review of respiratory disease.
[30] W. Paul,et al. IL-4 is required to generate and sustain in vivo IgE responses. , 1988, Journal of immunology.
[31] D. Hendrick,et al. Number and activity of inflammatory cells in bronchoalveolar lavage fluid in asthma and their relation to airway responsiveness. , 1988, Thorax.
[32] W. Mitzner,et al. Expression of airway hyperreactivity to acetylcholine as a simple autosomal recessive trait in mice , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] C. Corrigan,et al. T LYMPHOCYTE ACTIVATION IN ACUTE SEVERE ASTHMA , 1988, The Lancet.
[34] T. Suda,et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor , 1988, The Journal of experimental medicine.
[35] W. Seaman,et al. Induction of immune tolerance during administration of monoclonal antibody to L3T4 does not depend on depletion of L3T4+ cells. , 1988, Journal of immunology.
[36] J. Gamble,et al. Recombinant human interleukin 5 is a selective activator of human eosinophil function , 1988, The Journal of experimental medicine.
[37] A. Wardlaw,et al. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. , 1988, The American review of respiratory disease.
[38] I. G. Young,et al. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5). , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[39] P. Moseley,et al. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. , 1987, The American review of respiratory disease.
[40] D. Wofsy,et al. Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells. , 1986, Journal of immunology.
[41] R. Coffman,et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.
[42] F. Finkelman,et al. IgD-secreting murine plasmacytomas: identification and partial characterization of two IgD myeloma proteins. , 1981, Journal of immunology.